Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5198752
Max Phase: Preclinical
Molecular Formula: C16H15ClN2O
Molecular Weight: 286.76
Associated Items:
ID: ALA5198752
Max Phase: Preclinical
Molecular Formula: C16H15ClN2O
Molecular Weight: 286.76
Associated Items:
Canonical SMILES: CCCNC1=Nc2ccccc2Oc2ccc(Cl)cc21
Standard InChI: InChI=1S/C16H15ClN2O/c1-2-9-18-16-12-10-11(17)7-8-14(12)20-15-6-4-3-5-13(15)19-16/h3-8,10H,2,9H2,1H3,(H,18,19)
Standard InChI Key: QIIKUZNRHRSZOV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 286.76 | Molecular Weight (Monoisotopic): 286.0873 | AlogP: 4.52 | #Rotatable Bonds: 2 |
Polar Surface Area: 33.62 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.28 | CX LogP: 4.23 | CX LogD: 4.23 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.88 | Np Likeness Score: -0.82 |
1. Lin HC, Wu YL, Hsu CY, Lin MY, Chen LH, Shiau CW, Chiu HC.. (2022) Discovery of antipsychotic loxapine derivatives against intracellular multidrug-resistant bacteria., 13 (11.0): [PMID:36439974] [10.1039/d2md00182a] |
Source(1):